Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. David A. Plager, M.D.
EIR
•David A. Plager, M.D.•September 18, 2018

David A. Plager, M.D. – FDA EIR, Sep 18, 2018

Record Details

This FDA inspection, conducted at David A. Plager, M.D. from September 11-18, 2018, served as a follow-up to an earlier inspection in July 2016 that had resulted in an Official Action Indicated classification. The previous inspection uncovered multiple violations, including non-adherence to the investigational plan (such as enrolling subjects on prohibited medications, unqualified study staff, and underreporting of adverse events), failures to maintain accurate patient records, and lack of Institutional Review Board (IRB) approval for research changes. These findings led to an FDA Form 483 and an untitled letter, prompting Dr. Plager to commit to corrective actions. The purpose of the current inspection, carried out under Compliance Program 7348.811 for Clinical Investigators, was to verify the implementation of these corrective measures and evaluate the site's ongoing compliance with FDA regulations across its active studies, including Study 670. The comprehensive review covered areas such as protocol adherence, informed consent, data integrity, and investigational product accountability. Significantly, this inspection did not result in the issuance of an FDA Form 483, indicating resolution of the prior serious issues. The closing discussion, however, highlighted the importance of consistently applying Good Clinical Practice (GCP) standards. Specific points raised included proper methods for correcting errors in study documents, avoiding practices like using white-out, and ensuring subjects are adequately reminded on accurate completion of study diaries.

Company
David A. Plager, M.D.
Inspection date
September 18, 2018
Product type
drugs
Office
Center for Drug Evaluation and Research
People
  • Corrine M. Carter (investigator)
  • David A. Plager (investigator)
  • Neala Lane (other)
View Company Profile

ID · 820f493e-b786-43d3-a24b-a9d3b64f9334

Violation Codes1
21 CFR 312

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore David A. Plager, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.